We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Andrx Failed to Properly Investigate Product Deviations, Form 483 Says
Andrx Failed to Properly Investigate Product Deviations, Form 483 Says
May 5, 2006
Andrx failed to properly investigate product discrepancies and out-of-specification results, according to observations listed on the Form 483 the FDA issued to the company after the agency’s reinspection of the drugmaker’s plant in March.